Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO)
Clinical trial NCT01160094 · COMPLETED
Trial details
- NCT number
- NCT01160094
- Sponsor
- Novartis
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-02-01
- Primary completion
- 2013-07-01
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.